Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Haemorrhage
ADR ID BADD_A05391
ADR Hierarchy
24      Vascular disorders
24.07      Vascular haemorrhagic disorders
24.07.01      Haemorrhages NEC
24.07.01.002      Haemorrhage
Description Bleeding or escape of blood from a vessel. [MeSH]
MedDRA Code 10055798
MeSH ID D006470
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Bleeding | Blood loss of (NOS) | Haemorrhage NOS | Haemorrhage symptom | Haemorrhage, unspecified | Hemorrhage | Hemorrhage (NOS) | Hemorrhage term | Hemorrhage, unspecified | Microhaemorrhage | Microhemorrhage | Secondary and recurrent haemorrhage as an early complication of trauma | Secondary and recurrent hemorrhage as an early complication of trauma | Haemorrhage NOS aggravated | Hemorrhage aggravated | Hemorrhage symptom | Haemorrhage | Uncontrolled haemorrhage | Uncontrolled hemorrhage | Acute haemorrhage | Acute hemorrhage | Major bleed | Minor bleed | Haemorrhage aggravated | Symptomatic bleeding | BARC type 3a bleeding | BARC type 0 bleeding | BARC type 1 bleeding | BARC type 3b bleeding | BARC type 3c bleeding | BARC type 4 bleeding | BARC type 2 bleeding | Moderate bleeding - GUSTO classification | Minor bleeding - TIMI classification | Minimal bleeding - TIMI classification | Mild bleeding - GUSTO classification | Severe bleeding - GUSTO classification | Requiring medical attention bleeding - TIMI classification | Major bleeding - TIMI classification | Hemorrhages
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02482Acalabrutinib0.002485%
BADD_D02496Elagolix0.003949%
BADD_D02497Avatrombopag0.000457%
BADD_D02505Gilteritinib0.000168%
BADD_D02531Avapritinib0.000168%
BADD_D02552Encorafenib0.000168%
BADD_D02556Ferrous cation--
BADD_D02581Pacritinib0.000246%
BADD_D02586Radium ra-223 dichloride-
BADD_D02587Relugolix0.000734%
BADD_D02592Risdiplam0.002206%
BADD_D02609Zanubrutinib0.000224%
BADD_D02619Dienogest--
BADD_D02630Oxyphenbutazone--
BADD_D02631Phenylbutazone--
The 20th Page    First    Pre   20    Total 20 Pages
ADReCS-Target
ADR Term Drug Name Target